{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T10:59:03Z","timestamp":1780657143820,"version":"3.54.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014943","name":"sarepta therapeutics","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014943","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Person-reported outcomes measurement development for rare diseases has lagged behind that of more common diseases. In studies of caregivers\u00a0of patients with rare diseases, one relies on proxy report to characterize this disability. It is important to measure the child\u2019s disability accurately and comprehensively because it affects caregiver burden. We aimed to create a condition-specific caregiver proxy-report measure for Duchenne Muscular Dystrophy (DMD) in order to understand the impact of DMD on the caregiver. Drawing on relevant item banks from the Patient-Reported Outcome Measurement Information System (PROMIS), we sought to confirm their reliability and validity in the target sample of DMD caregivers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This web-based study recruited DMD caregivers via Rare Patient Voice, patient-advocacy groups, and word of mouth. Recruitment was stratified by age of the caregiver\u2019s child with DMD, which broadly represents stages of DMD progression: 2\u20137, 8\u201312, 13\u201317, and &gt;\u200918. Telephone interviews with DMD parent-caregivers pretested possible measures for content validity. The web-based study utilized an algorithm to categorize respondents\u2019 ambulatory status for tailored administration of PROMIS Parent-Proxy items as well as some new items developed based on caregiver interviews. Item response theory analyses were implemented.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The study sample included 521 DMD caregivers representing equally the four age strata. The proxy-report measure included the following domains: fatigue impact, strength impact, cognitive function, upper extremity function, positive affect, negative affect, sleep-device symptoms, and mobility. The first five domains had strong psychometric characteristics (unidimensionality; acceptable model fit; strong standardized factor loadings; high marginal reliability). Negative Affect, covering anger, anxiety, depressive symptoms, and psychological stress, fit a bifactor model with good model fit, high marginal reliability, and strong factor loadings. The Sleep-device symptoms domain was not unidimensional, and the mobility domain did not have a simple structure due to residual correlations among items at opposite end of the mobility-disability continuum. These two domain scores were retained as clinimetric indices (i.e., uncalibrated scales), to achieve the overall goal of having a content-valid DMD-specific measure across all stages of disease severity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The present study derived a DMD-specific proxy-report measure from PROMIS item banks and supplemental items that could potentially be utilized in caregiver research across all stages of the care recipient\u2019s DMD. Future research will focus on assessing the responsiveness and validity of the measure over time and its comparison to DMD patient self-report.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-021-02114-7","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T10:02:57Z","timestamp":1637575377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Measuring Duchenne muscular dystrophy impact: development of a proxy-reported measure derived from PROMIS item banks"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9173-7774","authenticated-orcid":false,"given":"Carolyn E.","family":"Schwartz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland B.","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Borowiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Gooch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana F.","family":"Audhya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,22]]},"reference":[{"issue":"2","key":"2114_CR1","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s11136-019-02320-8","volume":"29","author":"E Austin","year":"2020","unstructured":"Austin E, LeRouge C, Hartzler AL, Segal C, Lavallee DC. Capturing the patient voice: implementing patient-reported outcomes across the health system. Qual Life Res. 2020;29(2):347\u201355.","journal-title":"Qual Life Res"},{"key":"2114_CR2","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/d41573-019-00088-7","volume":"18","author":"MJ Calvert","year":"2019","unstructured":"Calvert MJ, O\u2019Connor DJ, Basch EM. Harnessing the patient voice in real-world evidence: the essential role of patient-reported outcomes. Nat Rev Drug Discovery. 2019;18:731\u20132. https:\/\/doi.org\/10.1038\/d41573-019-00088-7.","journal-title":"Nat Rev Drug Discovery"},{"issue":"12","key":"2114_CR3","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1002\/cam4.3018","volume":"9","author":"M Van Hemelrijck","year":"2020","unstructured":"Van Hemelrijck M, Sparano F, Moris L, Beyer K, Cottone F, Sprangers M, et al. Harnessing the patient voice in prostate cancer research: Systematic review on the use of patient-reported outcomes in randomized controlled trials to support clinical decision-making. Cancer Med. 2020;9(12):4039\u201358. https:\/\/doi.org\/10.1002\/cam4.3018.","journal-title":"Cancer Med"},{"issue":"3","key":"2114_CR4","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","volume":"11","author":"DF Cella","year":"1993","unstructured":"Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570\u20139.","journal-title":"J Clin Oncol"},{"issue":"5","key":"2114_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/BF00449426","volume":"2","author":"HE Niezgoda","year":"1993","unstructured":"Niezgoda HE, Pater J. A validation study of the domains of the core EORTC quality of life questionnaire. Qual Life Res. 1993;2(5):319\u201325.","journal-title":"Qual Life Res"},{"key":"2114_CR6","unstructured":"Ware J, Kosinski M, Bjorner J, Turner-Bowker D, Gandek B, Maruish, M. SF-36v2\u00ae Health Survey: a primer for healthcare providers. Lincoln, RI: QualityMetric Incorporated (2008)."},{"key":"2114_CR7","doi-asserted-by":"crossref","unstructured":"Ware JE, Jr, Bayliss MS, Rogers WH, Kosinski M, Tarlov AR. Differences in 4-year health outcomes for elderly and poor, chronically ill patients treated in HMO and fee-for-service systems. Results from the Medical Outcomes Study. JAMA, (1996);276(13), 1039\u201347.","DOI":"10.1001\/jama.276.13.1039b"},{"issue":"6846","key":"2114_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/bmj.305.6846.160","volume":"305","author":"JE Brazier","year":"1992","unstructured":"Brazier JE, Harper R, Jones N, O\u2019cathain A, Thomas K, Usherwood T, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305(6846):160\u20134.","journal-title":"BMJ"},{"issue":"4","key":"2114_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/qshc.7.4.209","volume":"7","author":"J Wight","year":"1998","unstructured":"Wight J, Edwards L, Brazier J, Walters S, Payne J, Brown C. The SF36 as an outcome measure of services for end stage renal failure. BMJ Qual Saf. 1998;7(4):209\u201321.","journal-title":"BMJ Qual Saf"},{"key":"2114_CR10","doi-asserted-by":"crossref","unstructured":"Kosinski M, Keller SD, Ware Jr, JE, Hatoum HT, Kong SX (1999) The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: relative validity of scales in relation to clinical measures of arthritis severity. Med Care, MS23\u201339.","DOI":"10.1097\/00005650-199905001-00003"},{"issue":"3","key":"2114_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/BF02260859","volume":"4","author":"B Vickrey","year":"1995","unstructured":"Vickrey B, Hays RD, Harooni R, Myers LW, Ellison GW. A health-related quality of life measure for multiple sclerosis. Qual Life Res. 1995;4(3):187\u2013206.","journal-title":"Qual Life Res"},{"issue":"4","key":"2114_CR12","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1023\/A:1008902728574","volume":"8","author":"A Jacoby","year":"1999","unstructured":"Jacoby A, Baker GA, Steen N, Buck D. The SF-36 as a health status measure for epilepsy: a psychometric assessment. Qual Life Res. 1999;8(4):351\u201364.","journal-title":"Qual Life Res"},{"key":"2114_CR13","doi-asserted-by":"crossref","unstructured":"Schwartz CE, Vollmer T, Lee H. Reliability and validity of two self-report measures of impairment and disability for MS. North American Research Consortium on Multiple Sclerosis Outcomes Study Group. Neurology, 1999; 52(1), 63\u201370.","DOI":"10.1212\/WNL.52.1.63"},{"issue":"8","key":"2114_CR14","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3899\/jrheum.181077","volume":"46","author":"A-M Orbai","year":"2019","unstructured":"Orbai A-M, Holland R, Leung YY, Tillett W, Goel N, Christensen R, et al. PsAID12 provisionally endorsed at OMERACT 2018 as core outcome measure to assess psoriatic arthritis-specific health-related quality of life in clinical trials. J Rheumatol. 2019;46(8):990\u20135.","journal-title":"J Rheumatol"},{"issue":"3","key":"2114_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/1529-0131(199906)12:3<163::AID-ART3>3.0.CO;2-Z","volume":"12","author":"XS Ren","year":"1999","unstructured":"Ren XS, Kazis L, Meenan RF. Short-form Arthritis Impact Measurement Scales 2: tests of reliability and validity among patients with osteoarthritis. Arthritis Care Res. 1999;12(3):163\u201371.","journal-title":"Arthritis Care Res"},{"issue":"6","key":"2114_CR16","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/j.1528-1157.2000.tb00240.x","volume":"41","author":"M Sabaz","year":"2000","unstructured":"Sabaz M, Cairns DR, Lawson JA, Nheu N, Bleasel AF, Bye AM. Validation of a new quality of life measure for children with epilepsy. Epilepsia. 2000;41(6):765\u201374.","journal-title":"Epilepsia"},{"issue":"3","key":"2114_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/CND.0b013e3181c5053b","volume":"11","author":"SE Davis","year":"2010","unstructured":"Davis SE, Hynan LS, Limbers CA, Andersen CM, Greene MC, Varni JW, et al. The PedsQL\u2122 in pediatric patients with Duchenne muscular dystrophy: feasibility, reliability, and validity of the Pediatric Quality of life inventory neuromuscular module and generic core scales. J Clin Neuromuscul Dis. 2010;11(3):97\u2013109.","journal-title":"J Clin Neuromuscul Dis"},{"key":"2114_CR18","doi-asserted-by":"crossref","unstructured":"Propp R. Development and psychometric evaluation of the muscular dystrophy child health index of life with disabilities (MDCHILD) questionnaire in children with Duchenne muscular dystrophy. University of Toronto (Canada); 2017.","DOI":"10.1111\/dmcn.13977"},{"issue":"19","key":"2114_CR19","doi-asserted-by":"publisher","first-page":"e2438","DOI":"10.1212\/WNL.0000000000011896","volume":"96","author":"PA Powell","year":"2021","unstructured":"Powell PA, Carlton J, Rowen D, Chandler F, Guglieri M, Brazier JE. Development of a new quality of life measure for Duchenne muscular dystrophy using mixed methods: the DMD-QoL. Neurology. 2021;96(19):e2438\u201350.","journal-title":"Neurology"},{"issue":"1","key":"2114_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12955-020-01511-z","volume":"18","author":"PA Powell","year":"2020","unstructured":"Powell PA, Carlton J, Woods HB, Mazzone P. Measuring quality of life in Duchenne muscular dystrophy: a systematic review of the content and structural validity of commonly used instruments. Health Qual Life Outcomes. 2020;18(1):1\u201326.","journal-title":"Health Qual Life Outcomes"},{"issue":"9","key":"2114_CR21","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1007\/s11136-017-1572-y","volume":"26","author":"CE Schwartz","year":"2017","unstructured":"Schwartz CE, Powell VE, Eldar-Lissai A. Measuring hemophilia caregiver burden: validation of the Hemophilia Caregiver Impact measure. Qual Life Res. 2017;26(9):2551\u201362. https:\/\/doi.org\/10.1007\/s11136-017-1572-y.","journal-title":"Qual Life Res"},{"issue":"5 Suppl 1","key":"2114_CR22","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/01.mlr.0000258615.42478.55","volume":"45","author":"D Cella","year":"2007","unstructured":"Cella D, Yount S, Rothrock N, Gershon R, Cook K, Reeve B, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care. 2007;45(5 Suppl 1):S3.","journal-title":"Med Care"},{"issue":"5","key":"2114_CR23","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1037\/hea0000741","volume":"38","author":"SE Yount","year":"2019","unstructured":"Yount SE, Cella D, Blozis S. PROMIS\u00ae: standardizing the patient voice in health psychology research and practice. Health Psychol. 2019;38(5):343.","journal-title":"Health Psychol"},{"issue":"7","key":"2114_CR24","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s11136-011-0025-2","volume":"21","author":"JW Varni","year":"2012","unstructured":"Varni JW, Thissen D, Stucky BD, Liu Y, Gorder H, Irwin DE, et al. PROMIS\u00ae Parent Proxy Report Scales: an item response theory analysis of the parent proxy report item banks. Qual Life Res. 2012;21(7):1223\u201340.","journal-title":"Qual Life Res"},{"issue":"1","key":"2114_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11136-007-9204-6","volume":"16","author":"D Cella","year":"2007","unstructured":"Cella D, Gershon R, Lai J-S, Choi S. The future of outcomes measurement: item banking, tailored short-forms, and computerized adaptive assessment. Qual Life Res. 2007;16(1):133\u201341.","journal-title":"Qual Life Res"},{"issue":"1","key":"2114_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13023-017-0631-3","volume":"12","author":"S Ryder","year":"2017","unstructured":"Ryder S, Leadley R, Armstrong N, Westwood M, De Kock S, Butt T, et al. The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review. Orphanet J Rare Dis. 2017;12(1):79.","journal-title":"Orphanet J Rare Dis"},{"key":"2114_CR27","doi-asserted-by":"crossref","unstructured":"Mendell JR, Shilling C, Leslie ND, Flanigan KM, al\u2010Dahhak R, Gastier\u2010Foster J, et al. Evidence\u2010based path to newborn screening for Duchenne muscular dystrophy. Ann Neurol.; 2012;71(3), 304\u201313.","DOI":"10.1002\/ana.23528"},{"issue":"10","key":"2114_CR28","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/ejhg.2012.301","volume":"21","author":"SJ Moat","year":"2013","unstructured":"Moat SJ, Bradley DM, Salmon R, Clarke A, Hartley L. Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK). Eur J Hum Genet. 2013;21(10):1049\u201353.","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"2114_CR29","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jpeds.2009.02.007","volume":"155","author":"E Ciafaloni","year":"2009","unstructured":"Ciafaloni E, Fox DJ, Pandya S, Westfield CP, Puzhankara S, Romitti PA, et al. Delayed diagnosis in Duchenne Muscular Dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet). J Pediatr. 2009;155(3):380\u20135.","journal-title":"J Pediatr"},{"key":"2114_CR30","doi-asserted-by":"crossref","unstructured":"Pane M, Lombardo ME, Alfieri P, D'Amico A, Bianco F, Vasco G, et al. Attention deficit hyperactivity disorder and cognitive function in Duchenne muscular dystrophy: phenotype-genotype correlation. J Pediatrics 2012; 61(4), 705\u20139.","DOI":"10.1016\/j.jpeds.2012.03.020"},{"issue":"3","key":"2114_CR31","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1136\/jnnp.2007.141721","volume":"80","author":"M Kohler","year":"2009","unstructured":"Kohler M, Clarenbach CF, Bahler C, Brack T, Russi EW, Bloch KE. Disability and survival in Duchenne muscular dystrophy. J Neurol Neurosurg Psychiatry. 2009;80(3):320\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"13","key":"2114_CR32","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3109\/09638288.2014.956187","volume":"37","author":"Y Hamdani","year":"2015","unstructured":"Hamdani Y, Mistry B, Gibson BE. Transitioning to adulthood with a progressive condition: best practice assumptions and individual experiences of young men with Duchenne muscular dystrophy. Disabil Rehabil. 2015;37(13):1144\u201351.","journal-title":"Disabil Rehabil"},{"issue":"5","key":"2114_CR33","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1037\/0021-9010.75.5.547","volume":"75","author":"RP Bagozzi","year":"1990","unstructured":"Bagozzi RP, Yi Y. Assessing method variance in multitrait-multimethod matrices: the case of self-reported affect and perceptions at work. J Appl Psychol. 1990;75(5):547.","journal-title":"J Appl Psychol"},{"key":"2114_CR34","doi-asserted-by":"crossref","unstructured":"Schwartz CE, Bode RK, Vollmer T. The symptom inventory disability-specific short forms for multiple sclerosis: reliability and factor structure. Arch Phys Med Rehabil., 2012; 93(9), 1629\u201336.","DOI":"10.1016\/j.apmr.2012.03.006"},{"key":"2114_CR35","doi-asserted-by":"crossref","unstructured":"Schwartz CE, Bode RK, Quaranto BR, Vollmer T. The symptom inventory disability-specific short forms for multiple sclerosis: construct validity, responsiveness, and interpretation. Arch Phys Med Rehabil. 2012; 93(9),1617\u201328.","DOI":"10.1016\/j.apmr.2012.01.012"},{"key":"2114_CR36","unstructured":"Lowes LP. Lowes lab ambulatory status algorithm. 2020; Personal Communication, Columbus, OH."},{"key":"2114_CR37","volume-title":"Item response theory for psychologists","author":"SE Embretson","year":"2000","unstructured":"Embretson SE, Reise SP. Item response theory for psychologists. London: Lawrence Erlbaum Associates; 2000."},{"key":"2114_CR38","doi-asserted-by":"crossref","unstructured":"Van der linden WJ, Hambleton RK. Handbook of modern item response theory. New York: Springer; 1997.","DOI":"10.1007\/978-1-4757-2691-6"},{"key":"2114_CR39","unstructured":"Muth\u00e9n LK, Muth\u00e9n BO. Mplus user's guide (Seventh ed.). 1998\u20132020; Los Angeles, CA: Muth\u00e9n & Muth\u00e9n."},{"key":"2114_CR40","doi-asserted-by":"crossref","unstructured":"Hu LT, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Eq Model Multidiscip J. 1999; 6(1), 1\u201355.","DOI":"10.1080\/10705519909540118"},{"issue":"4","key":"2114_CR41","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s11136-009-9464-4","volume":"18","author":"KF Cook","year":"2009","unstructured":"Cook KF, Kallen MA, Amtmann D. Having a fit: impact of number of items and distribution of data on traditional criteria for assessing IRT\u2019s unidimensionality assumption. Qual Life Res. 2009;18(4):447\u201360. https:\/\/doi.org\/10.1007\/s11136-009-9464-4.","journal-title":"Qual Life Res"},{"issue":"3","key":"2114_CR42","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1177\/0049124114543236","volume":"44","author":"DA Kenny","year":"2015","unstructured":"Kenny DA, Kaniskan B, McCoach DB. The performance of RMSEA in models with small degrees of freedom. Sociol Methods Res. 2015;44(3):486\u2013507.","journal-title":"Sociol Methods Res"},{"key":"2114_CR43","volume-title":"IRTPRO: Flexible, multidimensional, multiple categorical IRT modeling [Computer software]","author":"L Cai","year":"2011","unstructured":"Cai L, Du Toit S, Thissen D. IRTPRO: Flexible, multidimensional, multiple categorical IRT modeling [Computer software]. Chicago: Scientific Software International; 2011."},{"key":"2114_CR44","unstructured":"Samejima F. Graded response models. In Handbook of item response theory (pp. 95\u2013107): CRC Press; 2016."},{"key":"2114_CR45","unstructured":"Cai L, THissen D, Chapman C, du Toi J. Flexible multilevel multidimensional item response modeling and test scoring (flexMIRT(R)). (3.6.1 ed.). Chapel Hill, NC: Vector Psychometric Group, LLC; 2013\u201320."},{"issue":"1","key":"2114_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11136-007-9183-7","volume":"16","author":"SP Reise","year":"2007","unstructured":"Reise SP, Morizot J, Hays RD. The role of the bifactor model in resolving dimensionality issues in health outcomes measures. Qual Life Res. 2007;16(1):19\u201331.","journal-title":"Qual Life Res"},{"key":"2114_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jsp.2016.11.001","volume":"60","author":"MD Toland","year":"2017","unstructured":"Toland MD, Sulis I, Giambona F, Porcu M, Campbell JM. Introduction to bifactor polytomous item response theory analysis. J Sch Psychol. 2017;60:41\u201363.","journal-title":"J Sch Psychol"},{"key":"2114_CR48","volume-title":"IBM SPSS Statistics for Windows","author":"IBM","year":"2019","unstructured":"IBM. IBM SPSS Statistics for Windows. 26th ed. Armonk: IBM Corp; 2019.","edition":"26"},{"issue":"6","key":"2114_CR49","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/0021-9681(87)90027-0","volume":"40","author":"AR Feinstein","year":"1987","unstructured":"Feinstein AR. Clinimetric perspectives. J Chronic Dis. 1987;40(6):635\u201340.","journal-title":"J Chronic Dis"},{"issue":"1","key":"2114_CR50","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1089\/jpm.2005.8.121","volume":"8","author":"CE Schwartz","year":"2005","unstructured":"Schwartz CE, Merriman MP, Reed G, Byock I. Evaluation of the Missoula-VITAS Quality of Life Index - Revised: Research tool or clinical tool? J Palliat Med. 2005;8(1):121\u201335.","journal-title":"J Palliat Med"},{"issue":"1","key":"2114_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41687-019-0164-8","volume":"4","author":"CE Schwartz","year":"2020","unstructured":"Schwartz CE, Stark RB, Rapkin BD. Capturing patient experience: does quality-of-life appraisal entail a new class of measurement? J Patient-Rep Outcomes. 2020;4(1):1\u201311.","journal-title":"J Patient-Rep Outcomes"},{"key":"2114_CR52","doi-asserted-by":"crossref","unstructured":"Liang, M. H. Longitudinal construct validity: establishment of clinical meaning in patient evaluative instruments. [Review]. 2000; Medical Care, 38(9 Suppl), II84\u201390.","DOI":"10.1097\/00005650-200009002-00013"},{"issue":"1","key":"2114_CR53","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/BF00435438","volume":"1","author":"R Hays","year":"1992","unstructured":"Hays R, Hadorn D. Responsiveness to change: an aspect of validity, not a separate dimension. Qual Life Res. 1992;1(1):73\u20135.","journal-title":"Qual Life Res"},{"key":"2114_CR54","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0895-4356(01)00407-3","volume":"554","author":"DE Beaton","year":"2001","unstructured":"Beaton DE, Bombardier C, Katz JN, Wright JG. A taxonomy for responsiveness. J Clin Epidemiol. 2001;554:1204\u201317.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"2114_CR55","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jval.2016.10.003","volume":"20","author":"JR Kirwan","year":"2017","unstructured":"Kirwan JR, De Wit M, Frank L, Haywood KL, Salek S, Brace-McDonnell S, et al. Emerging guidelines for patient engagement in research. Value Health. 2017;20(3):481\u20136.","journal-title":"Value Health"},{"issue":"5","key":"2114_CR56","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s11136-014-0796-3","volume":"24","author":"K Haywood","year":"2015","unstructured":"Haywood K, Brett J, Salek S, Marlett N, Penman C, Shklarov S, et al. Patient and public engagement in health-related quality of life and patient-reported outcomes research: what is important and why should we care? Findings from the first ISOQOL patient engagement symposium. Qual Life Res. 2015;24(5):1069\u201376.","journal-title":"Qual Life Res"},{"key":"2114_CR57","doi-asserted-by":"crossref","unstructured":"Hoddinott P, Pollock A, O'Cathain A, Boyer I, Taylor J, MacDonald C, et al. How to incorporate patient and public perspectives into the design and conduct of research. F1000Research, 7; 2018.","DOI":"10.12688\/f1000research.15162.1"},{"issue":"1","key":"2114_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41687-019-0172-8","volume":"4","author":"J Carlton","year":"2020","unstructured":"Carlton J, Peasgood T, Khan S, Barber R, Bostock J, Keetharuth A. An emerging framework for fully incorporating public involvement (PI) into patient-reported outcome measures (PROMs). J Patient-Reported Outcomes. 2020;4(1):1\u201310.","journal-title":"J Patient-Reported Outcomes"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-02114-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-02114-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-02114-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T10:03:28Z","timestamp":1637575408000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-02114-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,22]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2114"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-02114-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,22]]},"assertion":[{"value":"20 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was reviewed and approved by the New England Independent Review Board (NEIRB #20201623). All participants provided informed consent prior to beginning the survey.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants agreed to their data being published in a journal article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"487"}}